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Antibiotic Resistance
By: Molly Kempa

“As a society we need to stand together
and begin implementing solutions
before antibiotic resistance becomes
the next great pandemic our
generation is forced to face.”

Molly Kempa
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For decades our society has been involved in a war
against microorganisms, specifically bacteria. Over the
years we have continued to design new products and
technologies to fight off the bacteria in our world.
Antimicrobials have been added to dish soaps, hand
soaps, toothpaste, shampoo and even deodorant in
hopes of stopping the threat of bacteria in our daily lives,
but why are these microbes such a threat? “The
calculated number of bacteria on Earth, above and below
ground, is 5x10^30. To put into perspective, the number
of bacteria on Earth is almost one billion times more than
the total number of stars in the universe” (Schmidt, 15).
It is true that some bacteria are harmful to humans, but
some bacteria have the opposite effect. Throughout our
body there are a variety of bacteria aiding in our daily
bodily functions. For example, we have bacteria that live
in our intestines that help break down certain foods and
absorb nutrients that otherwise we could not, and are
thus essential for our metabolism.

“To put into perspective,
the number of bacteria
on Earth is almost one
billion times more than
the total number of stars
in the universe.”

Antibiotic: a chemical substance
that either kills or inhibits the
growth of bacteria and other
microorganisms.

These commensal bacteria are found in many other
places, and in fact, the ratio of bacterial cells to human
cells is 10:1. This means that bacteria account for around
90 percent of cells on and within the human body, which
has prompted some scientists to now call us a “humanmicrobe hybrid” (Schmidt, 21). We can see that some
bacteria are actually beneficial to our lives and killing all
bacteria would not be advantageous. The true reason the
war on microbes started was because some bacteria
cause life-threatening illnesses if they are able to colonize
in the body where bacteria are not normally found in that
quantity. This threat of disease has led science to the
discovery and use of antibiotics. According to Dr. Selman
Waksman, an antibiotic is a “’chemical substance, of
microbial origin, that…(inhibits) the growth or metabolic
activity of bacteria and other microorganisms’”
(Spellberg, 39). For quite some time we thought we had
won the war on microbes due to antibiotics, but we were
wrong. Bacteria have evolved and fought back against
our medications and now the issue of antibiotic
resistance is a serious one facing our population.
Unfortunately, our society has not seemed to notice.

The Issue
Most people in the United States believe that
infectious diseases are not a major problem in our
nation, and that only third-world countries without
advanced medical technology have a substantial
number of people dying from infections. This public
opinion on infectious diseases is somewhat false.
While it is true that third-world countries statistically
show a greater incidence of deaths due to infectious
diseases, over 250,000 people in America die every
year from influenza, pneumonia and sepsis (Spellberg,
35). Infectious diseases remain among the top ten
causes of death in the United States and the world
regardless of the variety of antibiotics we have
available today. It would seem as though with the
current antibiotics, vaccines, and public health, that
infections would be no match for modern medicine.
Since 1935, there have been more than 150
antibiotics produced and each has aided health
professionals with curing patients of infectious
diseases (Spellberg, 43).
With this number of
antibiotics, infectious diseases should not be an issue,
and “in 1969 the US surgeon general, Dr. William
Stewart, is said to have declared, ‘It is time to close
the book on Infectious Diseases and declare the war
against pestilence won.’”(Spellberg, 22). This
statement shows the arrogance that developed in the
science community regarding antibiotics, and this
arrogance has only diminished slightly since. Over 40
years later, we are still discussing antibiotics and it is
clear the “war” has not been won. The World Health
Organization (WHO) expressed concern five years ago
that within the next decade there will be no effective
therapies against infectious diseases such as malaria,
tuberculosis and pneumonia (Schmidt, 6). These

Figure 1.
Bacteria
forming a
biofilm.

nosocomial infections have become progressively more
common in countries with advanced medical technology,
and are a consequence of the modern medical intensive
care used in hospitals today. It is clear that, “this
prevalent belief that infectious diseases had been
overcome by modern medical technology should be
remembered as one of the greatest blunders in the
history of biomedical sciences” (Spellberg, 34).
Why are people still falling deathly ill due to
bacteria? The answer is quite simple: resistance. Some
bacteria have developed resistance to the antibiotics we
currently use today and are therefore able to infect
individuals more easily without being impacted by the
use of medications as much as a non-resistant bacterium.
The bacteria are quite intelligent and have a variety of
mechanisms to endure harsh conditions: biofilms,
cooperation, communication, gene swapping and spore
formation (Schmidt, 7-8). We also see that the overuse
of antibiotics in our daily lives creates an environment to
train the bacteria to defend themselves against these
antimicrobial agents and antibiotics. “Much as a musician
or an athlete goes through endless hours of training to

“Soon there will be only
resistant bacteria
infecting patients with
few to no treatment
options unless a
resolution against
bacterial resistance can
be developed.”

hone his craft, antibiotics provide the training ground for
microbes in our midst to accelerate their training in how
to best handle…antibiotics” (Schmidt, xvii). This training
will allow the proliferation of resistant bacteria, and
infections by these bacteria will only trigger more
infections to occur, which will increase the morbidity and
mortality rates. Soon there will be only resistant bacteria
infecting patients with few to no treatment options
unless a resolution against bacterial resistance can be
developed.
Solutions to this problem seem to be quite simple.
In order to keep on top of the issue of antibiotic
resistance we need to continue to research and develop
new antibiotics to kill the bacteria who are resistance to
every other antibiotic. In reality, many pharmaceutical
companies have ceased research and production of new
antibiotics, and bacteria are becoming more and more
resistant as smaller quantities of antibiotics are being

created. With fewer antibiotics being produced the future
treatment of infectious diseases is narrowing. Another
traditional response would be to limit the use of current
antibiotics to only cases that require their use in order to
slow the progression of resistance, but currently the
medical community has not slowed down their use of
these medications. What will medical professionals treat
infections with when all the bacteria are resistant to
antibiotics? These resistant bacteria, commonly referred
to as super bugs, are not a work of fiction and should be
taken seriously in every part of the world.

Resistance

Figure 2. If a bacteria is sensitive to an antibiotic than it will not be
able to grow in its presence (petri dish on the left). The petri dish on
the right shows a bacterium that is resistant to each antibiotic disk on
the plate.

When examining the past use of antibiotics we can
discover that our society recklessly prescribed antibiotics
believing that they were the miracle drug needed to kill
bacteria causing infectious diseases. Antibiotics have
destroyed bacteria causing disease for decades, but their
extended use has led to the natural selection of the
bacteria that could survive through the harsh conditions
brought upon by antibiotics. Charles Darwin’s natural
selection theory states that the genes that allow an
organism the opportunity to procreate more than their
genetically different peers will be selected for, meaning
that they will survive longer due to their genetic
advantages. Antibiotics have selected for bacteria that
have the ability to gain resistance, and have wiped out
the bacteria that were unable to gain resistance. This
occurs because when an antibiotic is used there is a
small population of resistant bacteria left behind after the
use of the antibiotic that can continue to multiply. Also,
we must recognize that in order for an antibiotic to kill a
bacterium the bacteria must use the biochemical
pathway that the drug is targeting, and the antibiotic
must be able to infiltrate the bacterium in order to
destroy it (Spellberg, 44). These two factors are a means
by which bacteria can survive antibiotics due to inherent
resistance1.
Although bacteria are not considered complex
organisms, there are multiple methods that a bacterium
can implement in order to gain resistance. These
resistance mechanisms vary and can involve factors
ranging from the environment to genetics. The first
method of gaining resistance involves the DNA of
bacteria. A bacterium can get the genes for resistance
from the DNA of bacteria in the surrounding area. Once
1

Inherent resistance means that the bacterial is naturally resistant
to an antibiotic.

these bacteria have these resistance genes they now
have the ability to fight off certain antibiotics, and this
process of gaining resistance genes occurs continuously
in the microbial world. Gaining resistance genes occurs
via conjugation, transduction or transformation which are
all horizontal gene transfers. Conjugation is when there is
cell to cell contact between the two bacteria and the
genetic material is transferred in the form of a plasmid2.
The process of transformation is when genetic material is
taken up by the bacteria from its surrounding
environment, and transduction occurs when the bacteria
is infected with a virus specific to bacteria called a
bacteriophage, which can transfer DNA between bacteria.
Normally DNA transfers of this kind can only occur
between organisms of the same species, which is the
most specific of the classes of organisms. “In contrast,
bacteria can reach out, grab, and mix and match DNA
with bacteria of a different species, genera, family, order,
class and all the way up through the phyla level”
(Spellberg, 100).3 This means that bacteria can share
genetic information with organisms that are not closely
related to them while most other organisms cannot do
this.
2

A plasmid is a small piece of DNA that can be transferred between
cells.
3
Scientists put organisms into groups. There are 7 levels of
classifying living organisms: Kingdom, Phylum, Class, Order, Family,
Genus and Species. Kingdoms are the most general categories and
Species are the most specific.

“This process of gaining resistance
genes occurs continuously in the
microbial world.”

Figure 3. This graph represents the growth cycle of a
bacterium.
Another way for bacteria to gain resistance is
through mutations. Mutations in a bacteria’s DNA occur
during reproduction which is a process that is ridiculously
fast in bacteria. The time it takes some bacteria to
reproduce is somewhere between twenty to thirty
minutes (Spellberg, 98). Each time a bacteria reproduces
there is an opportunity for small changes in the DNA to
occur while replicating, and these changes are passed on
to the offspring of the bacteria via a vertical gene
transfer. Due to the accelerated rate of reproduction in
bacteria the odds are very high that mutations can occur,
and this translates into an increased chance of bacteria
gaining mutations that code for resistance genes. Once
the mutation coding for the resistance gene is transferred
to the progeny of the bacteria, the gene is within that
bacterium’s DNA unless another mutation occurs. “Of
every million progeny produced by a single dividing
bacterium, up to 30,000 may have unique, random DNA
mutations. These mutations may specifically enhance
their ability to survive despite hostile environmental
conditions, such as the presence of antibiotics”
(Spellberg, 99). Due to their ability to replicate swiftly it
is easy to see that bacteria are the most diverse and
numerous organisms on our planet.

Bacteria are also able to gain resistance through the
environment in which they reside, and bacteria are found
in almost every climate and environment on the planet.
One of the many ways the environment can impact the
resistance of a bacteria is whether or not the bacteria is
living around plants. “Most plants have developed a
formidable arsenal of chemical agents to ward off all
manner of pests. Bacteria that live around these plants
and their anti-pest arsenal must develop their own
defenses against the plant defenses” (Schmidt, 215).
These defenses the bacteria develop for protection are
similar to the antibiotics used today, and thus the
bacterium develops resistance against antibiotics. If the
bacteria are in an environment where the plants are
being sprayed with a fungiocide or a bacteriocide4, than
resistance can also increase due to the survival of the
resistant bacteria. These bacteria will then reproduce and
make offspring that possess their resistance genes as
discussed previously. The surrounding environment also
proves vital if there are heavy metals near the bacteria.
Heavy metals such as mercury, copper, lead, cadmium or
arsenic can contaminate the environment around
bacteria, and in response to this contamination the
bacteria use efflux pumps to get rid of the heavy metals
(Schmidt, 215).5 The bacteria have learned to adapt
these efflux pumps for use against antibiotics by
pumping out the antibiotic if it enters the bacterial cell.
Resistance can also occur from the environment due
to the incomplete digestion of antibiotics in the human
body. When a patient takes an antibiotic for an illness
their body’s digestive system is unable to absorb most of
the antibiotic. Due to this lack of absorption, most
4

Words ending in –cide refer to “the killing of”, thus bacteriocide
refers to agents that kill bacteria.
5

An efflux pump is comparable to a water pump that would pump
water out of a basement during a heavy flood (Schmidt, 215).

“Due to this lack of
absorption, most
antibiotics just pass
on through the
intestinal tract and
are excreted into
the environment.”

antibiotics just pass on through the intestinal tract and
are excreted into the environment. “It has been
estimated that 85-95 percent of antibiotics used remain
in their basic molecular form once they hit the
environment” (Schmidt, 210). Thus, these antibiotics that
make it out into the environment provide the bacteria
with the opportunity to “train” their resistance
mechanisms against that antibiotic.
There are many important factors that also need to
be addressed regarding how antibiotics gain resistance.
In today’s world our ability to travel is dramatically
increased since the beginning of the human race.
Anytime you want to travel you could take a car, bus,
train or an airplane to any part of the world you desire to
go. The increase in transportation mechanisms for
humans has also increased the transportation abilities of
bacteria. Bacteria can now travel to any place in the
world, and this is no different for resistant bacteria.

Outbreaks of resistant bacteria in one part of the world
can travel to any part of the world and cause an
outbreak there. This is an alarming notion to fathom
because we have no way to kill these resistant bacteria
and prevent them from spreading across the globe if an
outbreak were to occur. This provides an important
reason why our society needs to pay attention to this
issue.


Overuse
Just as antibiotics were introduced to the world,
incidents of resistance began to occur. It took only ten
years since the introduction of penicillin for
Staphylococcus aureus to become completely resistant to
penicillin and have this resistance spread across the
United States (Spellberg, 54). Ten years is a short time,
considering it takes more than ten years for an antibiotic
to be approved for use in patients since its discovery.
This makes it easier to understand why our society has
extended the use of antibiotics outside of treating
patients with infections because they want to kill off
these potentially harmful bacteria before they invade and
cause an infection. Although this extended use of
antibiotics and antimicrobial agents may have helped
with the incidence of infectious diseases over the years,
the extended use has also caused people to use these
agents where they are not necessary. A common
antibacterial agent used in many products is Triclosan,
and its wide use was estimated to be around one million

Figure 4. Products containing antimicrobial properties.

pounds each year (Schmidt, 211). These agents, such as
Triclosan, are found in a variety of products: soaps,
shampoos,
conditioners,
toothpaste,
cosmetics,
deodorant, shaving cream, cutting boards, plastic toys,
towels, mops and pesticides. Many companies have
developed a mindset that marketing their products as
antimicrobial or antibacterial will help them sell more
products thus gaining more of a profit. This mindset is a
significant concern to our issue of antibiotic resistance.
“A tragic irony is that recognition of the issue of
emerging infections is driving well-meaning people to use
antibacterial products where they are not neededfurthering the problem of antibiotic resistance” (Schmidt,
211). The use of these agents in products where they are
not needed exposes the bacteria that are around these
products to a small amount of an antimicrobial agent.
This small dose will kill most of the unwanted bacteria
that are susceptible, but there are still a slight
percentage of bacteria that develop resistance to the
agent. As we discussed earlier, the resistant bacteria are
then able to reproduce and more resistant offspring are
created. The resistant genes are then fixed into the
population of bacteria and will be effective against the
antibacterial agents used against it.
This issue of the overuse of antibacterial compounds
has been seen in the medical field as well. It is quite
common for people to get infections, and it is well-known
that these infections will most likely be treated with an
antibiotic. As patients we often desire to be treated with
an antibiotic, but strong caution needs to be used when
determining what to treat infections with. Antibiotics are
ineffective against infections that are not a result of
bacteria. Viral infections, for example, should not be
treated with antibiotics because the antibiotics will not
help the infection, they may kill the beneficial bacteria in

the body, or they may help the bacteria in the body gain
resistance to the antibiotic. This resistance could then be
transmitted to harmful invading bacteria in a future
infection eliminating the use of that particular antibiotic
in that patient experiencing the infection.
Another issue involving the use of antibiotics to fight
a patient’s infection is the actual duration and dosage of
the antibiotic taken. Some patients will stop the use of
the antibiotic they are taking for their infection at the
first signs of returning health because they feel they do
not need the remainder of their prescribed dose of
medication. Most patients would argue that this would be
a beneficial practice to aid in the fight against antibiotic
resistance due to less exposure of the bacteria to the
antibiotic, which would result in a lower probability the
bacteria could develop resistance. This statement is false,
the duration the antibiotic is prescribed for is carefully

“Self-administration of medication
has led to the selection of resistant
bacteria, and has also led to
bacteria that develop resistance to
multiple medications.”

calculated to fight off the infection, and stopping the
medication early can be detrimental to the recovery of
the patient as some can relapse and require further
treatment. The dosage of the antibiotic used in patients
is also shown to be dramatically increased from that of
bacteria. “Secretion into the environment of a trillionth of
a gram of antibiotic may well be enough to protect a
single, tiny bacterium from its neighbors. But a trillionth
of a gram of antibiotic would do nothing for a patient.
Rather, every day of antibiotic therapy requires that a
billion or trillion times more antibiotic be administered to
cure infections in patients” (Spellberg, 107). Due to the
amplified amount of antibiotics that need to be used in a
patient it is crucial that patients keep taking their
medication in order to recover from their bacterial
infection. Self-administration of medication has led to
the selection of resistant bacteria, and has also led to
bacteria that develop resistance to multiple medications.

It is also important to realize that the use of antibiotics
does not cause bacteria to gain resistance, but does
affect the rate at which resistance spreads amongst the
population of bacteria.
Another component affecting the issue of antibiotic
resistance involves the overuse of antibiotics in countries
that do not have the technology to effectively diagnosis
bacterial infections. “Suboptimal use of antimicrobials is a
particular problem in low-income countries, where there
is often a lack of laboratory data to guide prescribing,
and where antimicrobials are often ‘prescribed’ by nonmedical practitioners or are freely available in markets. In
such situations, sub-therapeutic doses are often taken…”
(Wax, 370).
In these low-income countries, the
availability of antibiotics to any and every one
dramatically increases the use of the drugs which results
in a greater selection of resistant bacteria due to the
inadequate amount of antibiotics taken. Although there is
a great incidence of selection of resistance in these lowincome countries, this is still an issue for the entire globe
due to travelling and migration.
The overuse of antibiotics is not just within the
human population. In fact, around 70 percent of
antibiotics produced in the United States are used on
farms. The use of antibiotics on farm animals, such as
livestock and chickens, accounts for most of the
antibiotics produced in America (“The Trouble with
Antibiotics”). Why are antibiotics being used in farm
animals? Farmers who raise animals for slaughter to
supply food for the nation are using antibiotics as a
means to promote growth in the animals, fight infections,
and prophylaxis. The antibiotics are mixed in the water
supply or the feed given to the animals, and farmers
have found that with the use of antibiotics the animals
gain as much weight with less feed and faster than if no
antibiotics were used. Because of this finding the farmers
have continued their use of antibiotics as a means to cut

antibiotics. These antibiotics can cause bacteria around
the plants to become resistant, can go airborne via dust
particles if experiencing a period with no rain, or can
wash off the field while experiencing a rain storm and
run off onto neighboring lawns. Although it has yet to be
proven that the use of antibiotics in animals is causing
infections of superbugs in the human population, there is
currently promising research being conducted that
provides evidence that resistance is spreading between
the two populations (animal to human) (“The Trouble
with Antibiotics”).

costs while raising the animals. “Most of the growth
promotion actions of the growth promoting antibiotics
are due to prevention of illness…It involves giving
antimicrobials to a large number of animals, over a long
period of time, at lower than therapeutic doses, a usage
pattern that is favorable for development of antimicrobial
resistance” (Lawrence, 189). Just as low doses of
antibiotics create an ideal environment for the training of
bacteria to become resistant in humans, the same effect
occurs in animals. These resistant bacteria found in
animals very well may be transmitted and cause incidents
of resistant bacterial infections in hospitals. This could be
possible through the consumption of the meat from these
animals containing resistant bacteria, or the fecal matter
used to fertilize fields of plants harvested for our food
supply. Remember that most antibiotics are not digested
by the body and are excreted into the environment
through waste. Manure that is used to fertilize fields from
animals that are treated with antibiotics will contain

“There is currently
promising research being
conducted that provides
evidence that resistance is
spreading between the
two populations (animal
to human)”

Future Outlook
It appears that antibiotics are one of the only
technologies on Earth that actually become less effective
the more it is used (Spellberg, 122). Members of the
science community are sensing that the technology of
antibiotics will soon be obsolete. According to a CDC
representative interviewed about antibiotic resistance
and the use of antibiotics on farms, “Anywhere you use
antibiotics you will have resistance.” (“The Trouble with
Antibiotics”). It is estimated by Dr. Walter Gilbert, a
Harvard professor, that “there may be a time down the
road when 80 percent to 90 percent of infections will be
resistant to all known antibiotics” (Schmidt, 4). The
devastation that would occur if the previous statement
were to become true is unfathomable. This issue is not
one to be taken lightly by the science community and the
public, but should be given a substantial amount of
attention in the coming years.
The obvious solution to this issue of bacteria gaining
resistance to antibiotics is to discover and produce new
antibiotics that the bacteria do not have a resistance to,
but most pharmaceutical companies have stopped
researching new antibiotics. This reduction is not
suggestive that all research is being decreased because
the area with the most significantly decreased research is
antibiotics (Spellberg, 90).
This reduction seen in
antibiotic research is occurring for a multitude of reasons,
but what it all comes down to is money. A
pharmaceutical company, above all else, is a business
that is looking to make a return on their investments.
The cost of researching and developing a new drug is
extensive, and companies are simply not making enough
of a return on their production and sales of antibiotics to
compensate for such a large amount of money spent on
researching new antibiotics.

Another factor that weighs against the research of
new antibiotics to fight against these superbugs is time.
The process involved in the discovery and production of a
new drug is lengthy. First, researchers need to discover a
new way to stop the bacteria from causing a harmful
infection in its host, and most mechanisms of action have
already been discovered over the last century. Thus, the
research stage of development of a new antibiotic would
be extensive because we have used all of our current
knowledge to make the antibiotics of today. Next, the
development of the new antibiotic is a long process. This
process entails ensuring that the new antibiotic is drugable, which means “the compound used in the
medication has to be active at concentrations that are
feasible for administration to people” (Spellberg, 114).
The new medication must also be safe and effective in
animals first and then humans. Researchers would first
have to test the new antibiotic in animals to make sure
there are no harmful side effects, and that the drug
performs as intended. After the trials involving animals

are completed with favorable results, the researchers will
then get approval to run a clinical trial involving four
phases. Phase 1 of a clinical trial involves testing the
drug on healthy human volunteers to see if there are any
adverse effects. Phase 2 and 3 of a clinical trial tests the
new drug on actual patients, and Phase 4 involves the
surveillance of the new medication after it is approved for
public use to make sure no other side effects occur once
the public begins using the medication. As you can see
this process would take a long period of time to
complete, which is a great deterrent for pharmaceutical
companies.
The lack of federal funding for new antibiotics is
also a factor in the reduction of research and
development of new antibiotics. Diseases such as
HIV/AIDS, have substantial federal funding available to
pay for the cost of developing anti-HIV medications
because the government and the public believe that

HIV is a huge issue needing a resolution. This was not
always the case of HIV/AIDS. Before this disease was a
serious issue in our country and throughout the world,
few people paid any attention to its threat. It was only
after a noteworthy portion of the homosexual population
began contracting this disease that the public began to
respond to the issue. Resistance to antibiotics is another
issue of similar magnitude that needs attention, but we
should not wait until it is a major issue to act. Now is the
time for the public to realize that antibiotics are
beginning to fail as a treatment method and that
precautions need to be taken against this threat. It is
only when the public believes antibiotic resistance is an
issue that our elected officials in the government will act
against the issue.
There are a variety of steps that need to be taken in
order to reduce the implications of antibiotic resistance.
One of the first steps to be taken is to compile a list of
the most problematic bacterial infections our society is
facing today and ones that we will face in the near future
(Spellberg, 181). This list will allow researchers to focus
on the infections we are experiencing the most hardships
with first, and thus hopefully develop new antibiotics for
those infections before moving on to others. The next
step would be for the government to provide incentives
to pharmaceutical companies in order to get them to
start researching new antibiotics again. An incentive to
pharmaceutical companies that could cut cost of
researching new antibiotics in some way, such as a tax
break, could promote increases in research in this area.
Another step that should be taken involves the
development of vaccines. “Since defects in host immune
systems predispose patients to developing drug-resistant
infections, finding a way to boost the immune system

“It is only when the
public believes
antibiotic resistance
is an issue that our
elected officials in
the government will
act against the
issue.”

should be an effective way to prevent or treat such
infections…Vaccines and antibiotics complement one
another, and both are needed” (Spellberg, 194). The
current method of treating a bacterial infection is to
prescribe a patient an antibiotic and send them on their
way to the pharmacy. We can see that this method is a
short term fix to a long term problem. Not only does the
science community need to develop new antibiotics for
infections, they also need to broaden their method to
how to kill off the bacteria. The use of vaccines that can
provide extra immune support to the patient while
experiencing an infection could prove to be quite
beneficial to the recovery of the patient. It is essential
that the medical community develop combination
therapies to help fight off the bacteria causing the
infections in order to help with the never ending issue of
antibiotic resistant. Bacteria will always possess their
resistance mechanisms against antibiotics, and humans
need to realize that just using antibiotics may not always
be the answer to treating bacterial infections.
Another solution to the problem of antibiotic
resistance would be to monitor the amount of antibiotics
used on farms. Currently farmers are not required by law
to provide any data regarding their use of antibiotics
while raising animals, and this should be changed
immediately. About 40 years ago, the FDA tried to reduce
the amount of tetracycline and penicillin used on farms,
but everyone opposed the reduction due to the lack of
evidence between the use of antibiotics on farms and
infections in humans. “Relatively few studies have been
done to evaluate the distribution of antibiotic resistance
patterns in environmental bacteria, especially bacteria in
sites outside of farms or areas of human settlement”
(Wax, 18). The more antibiotics we use to raise animals
the more selective pressure we put on the environment
to kill off susceptible bacteria leaving behind resistant
bacteria. One way to decrease the amount of resistant

bacteria in the environment is to decrease the use of
antibiotics. The use of a surveillance system that
monitors the use of antibiotics on farms will help control
the amount of antibiotics used, and this will decrease the
production of superbugs. Last year there were proposals
made to Congress that required farmers to report
information regarding their use of antibiotics, but the
proposals did not pass. Today, the FDA is working on
another approach that involves the pharmaceutical
companies to cease production of the antibiotics that are
commonly used for growth promotion on farms (“The
Trouble with Antibiotics”).
Food and safety regulations should also be
implemented in regards to the amount of antibiotics that
are safe to use in raising farm animals to help control the
rate at which antibiotic resistance is spreading, and help
keep the public safe from antibiotic-resistant bacteria
that are found to be contaminating meats. Scientists
should also conduct more research to link the use of
antibiotics on farms to the prevalence of superbugs in
humans in order to provide the public with more
evidence which would fuel this issue’s prominence.

“The more antibiotics we
use to raise animals the
more selective pressure we
put on the environment to
kill off susceptible bacteria
leaving behind resistant
bacteria.”

Prevention

Figure 5. Hand washing is still the most
important factor in prevention of illness.

As a society we must all realize that bacteria are
essential to our lives, and they are critical for the survival
of the planet. “For example, bacteria are the only
organisms on the planet that are capable of fixing
nitrogen from the atmosphere into the food chain. This
process is essential to the creation of macromolecules,
such as proteins, that are the basis of life. Bacteria also
produce a variety of vitamins and cofactors essential to
our diet, such as vitamin K” (Spellberg, 103). The human
population must learn to coexist with these organisms
that have managed to develop a bad reputation since the
beginning of life on Earth. Yes, some bacteria are
harmful and should be killed, but many we come in
contact with are not harmful and exposure to these
bacteria is a normal part of life. The most important way
to protect your body from an infection is to keep yourself
healthy. This consists of many factors: healthy diet,
adequate amount of rest, exercise and hand washing.
Eating a healthy diet will make sure your body is getting
the essential nutrition it requires, and this in turn will
keep your immune system running more effectively.
“Sleep is one of the most fundamentally essential
components needed to maintain strong immune
defenses, efficient energy production and appropriate
recovery and repair functions” (Schmidt, 192). Health
professionals suggest that you get 8 to 9 hours of sleep
each night. It has also been shown that moderate
exercise may increase your immune response by
increasing your white blood cell count. The last factor,
hand washing, is still the most powerful action to prevent
infections. All of these factors will lead to an increase in
your immune system, and this will help you fight off any
kind of bacteria that is trying to invade your body.

In regards to the use of antibiotics there are two
rules that patients can follow to help the issue of
antibiotic resistance. First, do not ask your physician to
prescribe you an antibiotic. Let your doctor determine
whether your infection is a result of a bacterial infection,
and if it is, then they will prescribe you the proper
antibiotic for the infection. The pressure that a patient
can put on a doctor to prescribe unnecessary medication
is a continuous issue in the health profession, and one
way to eliminate this issue is for you, the patient, to stop
asking for unneeded medications. The second way to
help prevent antibiotic resistance is to take the full
dosage of antibiotic prescribed. “If a drug concentration
drops below the MIC before infection is cleared, residual
pathogens may regrow and cause disease relapse.
During regrowth, spontaneous errors in DNA replication
generate new resistant mutants and the resulting mutant
populations will be enriched when antibiotic therapy is
restarted” (Drlica, 82). 6 In order for the antibiotic to be
effective in killing the bacteria the MIC must be met, and
this is why it is essential that a full dose of the antibiotic
is taken as directed. If for some reason a patient stops
their treatment of the antibiotic before prescribed to do
so, than some bacteria causing the infection may still be
living. These bacteria can then reproduce and possibly
develop resistance via mutations in their DNA or a
horizontal gene transfer from a neighboring resistant
bacterium.

6

MIC is the minimum inhibitory concentration, or the minimum
amount of a drug necessary to inhibit growth of the bacteria. If a
drug concentration falls below this level than it not effective, and the
bacteria can continue to grow.

There are a few more preventative measures that
each person can begin today that can aid in the
prevention of infections, which will ultimately decrease
the use of antibiotics. The first preventative measure is
actually the reduction of the germ free home movement
that our society has grown to desire. There are two
major issues regarding this movement, and the first is
the negative impact it may have on people, especially
children. As a child you were involved in anything and
everything that interested you, and not all of these things
were germ free. For example, a young child puts objects
in their mouth. Any new object a child comes in contact
with they put in their mouth as a means to learn and
discover all about the new object. This practice is not a
germ free one, and is actually quite beneficial to that
child. Your child’s body needs to be exposed to the world
around it in order to build his/her immune system, and
cleaning your home so it is completely germ free would
be a disservice to your child’s development of his/her
immune system. The second issue with the movement

“Cleaning your home so it is
completely germ free would be a
disservice to your child’s
development of his/her immune
system.”

Figure 6. Examples of products consisting of
probiotics.

toward a germ free home is the development of
resistance against the disinfectants and antiseptics used
to clean the home. “Resistance to antiseptics and
disinfectants may remove our last line of defense against
pathogens on our skin and on environmental surfaces; it
could seriously compromise surgical procedures” (Drlica,
84). In order to keep disinfectants and antiseptics
effective we must not overuse them.
Probiotics are another means by which you can
strengthen your immune system which will in turn
strengthen your body’s response to an infection.
Probiotics
are
“selective,
nonpathogenic,
living
microorganisms, including some commensal bacterial
flora, which have beneficial effects on host health and
disease prevention and/or treatment” (Lawrence, 213214). The sources of probiotics in the diet are dairy
products, products that have been fermented, and
probiotic supplements. The mechanisms by which
probiotics can help your immune system fight off an
infection are the production of acids resulting in an acidic
environment, and this causes a decrease in the number

of microorganisms. The other mechanism consists of the
production of bacteriocins which inhibit the growth of the
microorganisms infecting the host.7 Some of the major
health effects of probiotics are: control overgrowth of
intestinal bacteria, antioxidant activity, suppression of
pathogenic microorganisms found in the intestines,
immune potentiating activity, aid in breakdown of
nutrients properly, reduction of the production of toxins
and prevent cardiovascular disease (Lawrence, 213-214).
The consumption of probiotics is an indirect method to
help people in their fight against antibiotic resistance by
supporting the immune system in fighting off harmful
bacteria when they first invade and attempt to colonize
the body.
Health education and spreading the word are the
two key methods of prevention. Gaining the knowledge
about this issue will enlighten the world about how
serious an issue antibiotic resistance is, and what
preventative measures need to be taken. “Not only has
the general public not known about the lack of antibiotic
development, or the extent of the problem, it turns out
that many physicians do not know either. Nor do general
medical journals appear to be particularly interested in
the problem” (Spellberg, 196). Spreading the information
you learn about this topic is the only way that people will
begin to notice and start to care. Throughout history
7

Bacteriocins are toxins made of proteins that will inhibit the growth
of microorganisms.

there is a general trend that the issues that get the most
attention are the ones that affect the greatest number of
people, but antibiotic resistance is not getting the
attention it deserves. This issue does affect a large
number of people, and will eventually affect the entire
world population if a resolution plan is not developed
soon. As a society we need to stand together and begin
implementing solutions before antibiotic resistance
becomes the next great pandemic our generation is
forced to face.

“Throughout history there
is a general trend that
issues that get the most
attention are the ones that
affect the greatest number
of people, but antibiotic
resistance is not getting the
attention it deserves.”
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